NCT04427774 2021-07-20
A Study of Surufatinib Plus Sintilimab in Patients With Advanced Solid Tumor
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1 Terminated
Clinical Trials
4 trialsNCT02133157 2020-07-08
HMPL
Hutchmed
Phase 1 Completed
NCT03879057 2019-10-01
Trial of Surufatinib Combined With JS001 in the Treatment of Advanced Solid Tumors
Peking University
Phase 1 Unknown
NCT02267967 2018-11-13
Phase Ib/II Study of Sulfatinib in Treating Advanced Neuroendocrine Tumors
Hutchmed
Phase 1 Completed